Scarica l'app Stockscreener
16.01
2.04%
0.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$15.69
Aprire:
$15.86
Volume 24 ore:
1.17M
Relative Volume:
0.71
Capitalizzazione di mercato:
$3.00B
Reddito:
$514.85M
Utile/perdita netta:
$328.86M
Rapporto P/E:
9.0167
EPS:
1.7756
Flusso di cassa netto:
$311.25M
1 W Prestazione:
+0.31%
1M Prestazione:
+3.29%
6M Prestazione:
-13.88%
1 anno Prestazione:
-14.57%
Intervallo 1D:
$15.81
$16.07
Intervallo di 1 settimana:
$15.59
$16.32
Portata 52W:
$13.70
$19.67
Hercules Capital Inc Stock (HTGC) Company Profile
Nome
Hercules Capital Inc
Settore
Industria
Telefono
650-289-3060
Indirizzo
1 NORTH B STREET, SAN MATEO, CA
Compare HTGC vs BLK, BX, BN, KKR, BAM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HTGC
Hercules Capital Inc
|
16.01 | 3.00B | 514.85M | 328.86M | 311.25M | 1.7756 |
BLK
Blackrock Inc
|
1,036.11 | 160.59B | 26.28B | 6.75B | 3.76B | 38.77 |
BX
Blackstone Inc
|
123.09 | 150.36B | 14.88B | 6.10B | 869.79M | 3.8977 |
BN
Brookfield Corp
|
43.73 | 107.19B | 77.61B | 4.06B | -8.36B | 0.497 |
KKR
Kkr Co Inc
|
96.94 | 87.04B | 22.38B | 5.74B | 8.54B | 2.9339 |
BAM
Brookfield Asset Management Ltd
|
46.72 | 74.60B | 5.07B | 2.48B | 2.37B | 1.5532 |
Hercules Capital Inc Stock (HTGC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-11-04 | Aggiornamento | Compass Point | Neutral → Buy |
| 2024-12-12 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-01-16 | Downgrade | Compass Point | Buy → Neutral |
| 2023-11-21 | Iniziato | UBS | Neutral |
| 2023-08-30 | Aggiornamento | Compass Point | Neutral → Buy |
| 2023-08-04 | Aggiornamento | Keefe Bruyette | Underperform → Mkt Perform |
| 2023-04-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-03-13 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
| 2022-07-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-04-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-04-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-02-08 | Downgrade | Compass Point | Buy → Neutral |
| 2021-04-28 | Iniziato | Oppenheimer | Outperform |
| 2021-03-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-11-02 | Ripresa | JMP Securities | Mkt Outperform |
| 2020-07-31 | Aggiornamento | Compass Point | Neutral → Buy |
| 2020-07-20 | Ripresa | Piper Sandler | Overweight |
| 2020-06-19 | Aggiornamento | Janney | Neutral → Buy |
| 2020-03-31 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-11-04 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-05-06 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2019-03-13 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-03-13 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| 2018-02-07 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2018-02-06 | Aggiornamento | Sandler O'Neill | Hold → Buy |
| 2017-11-20 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-11-03 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2017-10-25 | Iniziato | Wedbush | Neutral |
| 2017-10-02 | Ripresa | FBR & Co. | Buy |
| 2017-09-08 | Aggiornamento | Compass Point | Neutral → Buy |
| 2017-08-07 | Ripresa | JMP Securities | Mkt Outperform |
| 2017-08-04 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2017-02-24 | Reiterato | FBR & Co. | Outperform |
Mostra tutto
Hercules Capital Inc Borsa (HTGC) Ultime notizie
What's Behind the Sudden Surge in Bearish Bets on Hercules Capital - Kavout | AI
10% Average Income2 High-Yield Gems Every Investor Should Know - Seeking Alpha
ETFs Investing in Hercules Capital, Inc. Stocks - TradingView
Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Alector Ends GSK Collaboration, Retires Hercules Capital Debt - TipRanks
Hercules Capital (HTGC) Q3 2024 earnings summary - Quartr
(HTGC) Risk Channels and Responsive Allocation - Stock Traders Daily
HTGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
How Investors May Respond To Hercules Capital (HTGC) ESOP Equity Shelf And Potential Dilution Risk - Yahoo Finance
What Hercules Capital (HTGC)'s ESOP Shelf Registration Means For Shareholders - simplywall.st
HTGC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
1 Financials Stock with Impressive Fundamentals and 2 We Find Risky - Yahoo Finance
HTGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Hercules Capital, Inc. (HTGC) Investigation: Bronstein, Gewirtz - The National Law Review
Precision Trading with Hercules Capital Inc. 6.25% Notes Due 2033 (HCXY) Risk Zones - Stock Traders Daily
HTGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
4DMT SECURES STRATEGIC CREDIT FACILITY FOR UP TO $200 MILLION FROM HERCULES CAPITAL - Moomoo
Hercules Capital, Inc. Actuals & Estimates (NYSE:HTGC) - TradingView
4D Molecular Therapeutics secures $200M credit facility - Investing.com UK
4D Molecular Therapeutics Secures Strategic Credit Facility for Up to $200 Million from Hercules Capital - marketscreener.com
4D Molecular Therapeutics Secures Up to $200 Million Term Loan Facility From Hercules Capital - TradingView
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital - The Manila Times
Press Release: 4DMT Secures Strategic Credit Facility for up to $200 Million From Hercules Capital - Moomoo
HTGCHercules Capital Inc Latest SEC Filings - Finviz
Price to earnings forward of Hercules Capital, Inc. – NYSE:HTGC - TradingView
Price to sales forward of Hercules Capital, Inc. – NYSE:HTGC - TradingView
Price to earnings forward of Hercules Capital, Inc. – HAM:19H - TradingView
Price to book forward of Hercules Capital, Inc. – HAM:19H - TradingView
Enterprise value to revenue forward of Hercules Capital, Inc. – HAM:19H - TradingView
Price to sales forward of Hercules Capital, Inc. – HAM:19H - TradingView
Hercules Capital (HTGC) Rises On Estimate Revisions But Is The Valuation Case Priced In - Sahm
(HTGC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Enterprise value to revenue forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Price to book forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
19H Forecast — Price Target — Prediction for 2027 - TradingView
Hercules Capital, Inc. Actuals & Estimates (LSE:0J4M) - TradingView
Price to earnings forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Enterprise value to EBIT forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Price to sales forward of Hercules Capital, Inc. – LSX:A0ERTZ - TradingView
Dyne Therapeutics (DYN) Expands Term Loan Facility with Hercules Capital by $400M to Advance Clinical Pipeline - Insider Monkey
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet - Yahoo Finance
Hercules Capital: This 12% Yield Is My Top Pick For The Back Half (NYSE:HTGC) - Seeking Alpha
Form 4 Hercules Capital Inc For: 23 June By Investing.com - Investing.com South Africa
Hercules Capital (HCXY) director gets 3,873-share restricted stock award - Stock Titan
Director Robert Badavas gets 3,873-share grant at Hercules Capital (HCXY) - Stock Titan
Hercules Capital (NYSE: HTGC) director receives 3,873-share restricted stock award - Stock Titan
Hercules Capital (NYSE: HTGC) director receives 3,873-share restricted grant - Stock Titan
Hercules Capital Inc Azioni (HTGC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hercules Capital Inc Azioni (HTGC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Loo Wade | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
14,050 |
| Fallon Thomas J | Director |
Mar 26 '26 |
Buy |
14.30 |
7,300 |
104,390 |
157,669 |
| Aguirre DeAnne | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
10,749 |
| Randhawa Paramjeet K | Director |
Mar 26 '26 |
Buy |
14.35 |
2,926 |
41,988 |
22,486 |
| CROWELL GAYLE A | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
97,589 |
| Theodosopoulos Nikos | Director |
Mar 26 '26 |
Buy |
14.35 |
7,317 |
104,999 |
29,362 |
| Randhawa Paramjeet K | Director |
Mar 04 '26 |
Buy |
14.78 |
3,050 |
45,079 |
19,560 |
| Theodosopoulos Nikos | Director |
Feb 27 '26 |
Buy |
14.21 |
2,600 |
36,946 |
21,523 |
| BADAVAS ROBERT P | Director |
Feb 27 '26 |
Buy |
14.27 |
5,000 |
71,350 |
122,073 |
| Botelho Kiersten Zaza | Chief Legal Officer & CCO |
Feb 27 '26 |
Buy |
14.21 |
1,300 |
18,473 |
93,336 |
0.36%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):